These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 1659876)
21. Apparent mineralocorticoid excess, pseudohypoaldosteronism, and urinary electrolyte excretion: toward a redefinition of mineralocorticoid action. Funder JW; Pearce PT; Myles K; Roy LP FASEB J; 1990 Nov; 4(14):3234-8. PubMed ID: 2172062 [TBL] [Abstract][Full Text] [Related]
22. Mineralocorticoid effector mechanism in human mononuclear leukocytes. Armanini D; Wehling M; Weber PC J Steroid Biochem; 1987; 27(4-6):967-70. PubMed ID: 2826915 [TBL] [Abstract][Full Text] [Related]
23. The enigma of pseudohypoaldosteronism. Zennaro MC; Borensztein P; Soubrier F; Armanini D; Corvol P Steroids; 1994 Feb; 59(2):96-9. PubMed ID: 8191555 [TBL] [Abstract][Full Text] [Related]
24. Renin-aldosterone system evaluation over four decades in an extended family with autosomal dominant pseudohypoaldosteronism due to a deletion in the NR3C2 gene. Hanukoglu A; Vargas-Poussou R; Landau Z; Yosovich K; Hureaux M; Zennaro MC J Steroid Biochem Mol Biol; 2020 Nov; 204():105755. PubMed ID: 33017655 [TBL] [Abstract][Full Text] [Related]
27. Pseudohypoaldosteronism type 1 due to a novel mutation in the mineralocorticoid receptor gene. Loomba-Albrecht LA; Nagel M; Bremer AA Horm Res Paediatr; 2010; 73(6):482-6. PubMed ID: 20453518 [TBL] [Abstract][Full Text] [Related]
28. A novel nonsense mutation of the mineralocorticoid receptor gene in a Swedish family with pseudohypoaldosteronism type I (PHA1). Nyström AM; Bondeson ML; Skanke N; Mårtensson J; Strömberg B; Gustafsson J; Annerén G J Clin Endocrinol Metab; 2004 Jan; 89(1):227-31. PubMed ID: 14715854 [TBL] [Abstract][Full Text] [Related]
29. Lack of effect of aldosterone on intracellular sodium and potassium in mononuclear leucocytes from patients with pseudohypoaldosteronism. Wehling M; Kuhnle U; Witzgall H; Weber PC; Armanini D Clin Endocrinol (Oxf); 1988 Jan; 28(1):67-74. PubMed ID: 3168302 [TBL] [Abstract][Full Text] [Related]
31. Evidence for genetic heterogeneity of pseudohypoaldosteronism type 1: identification of a novel mutation in the human mineralocorticoid receptor in one sporadic case and no mutations in two autosomal dominant kindreds. Viemann M; Peter M; López-Siguero JP; Simic-Schleicher G; Sippell WG J Clin Endocrinol Metab; 2001 May; 86(5):2056-9. PubMed ID: 11344206 [TBL] [Abstract][Full Text] [Related]
33. Mineralocorticoid receptors in rat anterior pituitary: toward a redefinition of "mineralocorticoid hormone". Krozowski Z; Funder JW Endocrinology; 1981 Oct; 109(4):1221-4. PubMed ID: 6269837 [TBL] [Abstract][Full Text] [Related]
34. Different inactivating mutations of the mineralocorticoid receptor in fourteen families affected by type I pseudohypoaldosteronism. Sartorato P; Lapeyraque AL; Armanini D; Kuhnle U; Khaldi Y; Salomon R; Abadie V; Di Battista E; Naselli A; Racine A; Bosio M; Caprio M; Poulet-Young V; Chabrolle JP; Niaudet P; De Gennes C; Lecornec MH; Poisson E; Fusco AM; Loli P; Lombès M; Zennaro MC J Clin Endocrinol Metab; 2003 Jun; 88(6):2508-17. PubMed ID: 12788847 [TBL] [Abstract][Full Text] [Related]
35. Type I pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects. Hanukoglu A J Clin Endocrinol Metab; 1991 Nov; 73(5):936-44. PubMed ID: 1939532 [TBL] [Abstract][Full Text] [Related]
36. Syndromes of impaired ion handling in the distal nephron: pseudohypoaldosteronism and familial hyperkalemic hypertension. Kostakis ID; Cholidou KG; Perrea D Hormones (Athens); 2012; 11(1):31-53. PubMed ID: 22450343 [TBL] [Abstract][Full Text] [Related]
37. Autosomal-dominant pseudohypoaldosteronism type 1 in a Turkish family is associated with a novel nonsense mutation in the human mineralocorticoid receptor gene. Riepe FG; Krone N; Morlot M; Peter M; Sippell WG; Partsch CJ J Clin Endocrinol Metab; 2004 May; 89(5):2150-2. PubMed ID: 15126534 [TBL] [Abstract][Full Text] [Related]
39. Pseudohypoaldosteronism due to renal and multisystem resistance to mineralocorticoids respond differently to carbenoxolone. Hanukoglu A; Joy O; Steinitz M; Rosler A; Hanukoglu I J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):105-12. PubMed ID: 9182864 [TBL] [Abstract][Full Text] [Related]